Cargando…
Phlegmasia cerulea dolens during the SARS-COV-2 pandemic: What management ?
• PCD is a serious disease, because of its important morbi-mortality. • The suspicion of COVID-19 in front of any severe deep vein thrombosis. • Aponeurotomy and rapid medical management of compartment syndrome, can reduce the morbidity and mortality of phlegmasia cerulea dolens. • Blue phlebitis or...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254390/ https://www.ncbi.nlm.nih.gov/pubmed/34249354 http://dx.doi.org/10.1016/j.amsu.2021.102541 |
Sumario: | • PCD is a serious disease, because of its important morbi-mortality. • The suspicion of COVID-19 in front of any severe deep vein thrombosis. • Aponeurotomy and rapid medical management of compartment syndrome, can reduce the morbidity and mortality of phlegmasia cerulea dolens. • Blue phlebitis or also called ischemic phlebitis; is a real medico-surgical emergency. |
---|